Cross Border Action: The People's Round on the Trans Pacific Partnership

In the Truthout article below, we can see clearly the devastating results that come from favoring corporate protection over people’s health. If Congress approves the Trans-Pacific Partnership, generic versions of medical breakthroughs would not be available for “a mandatory minimum of five to eight years of data protection.”

Obama says, “This partnership levels the playing field for our farmers, ranchers, and manufacturers.”

The TPP does not “level the playing field,” for generic drugs; instead it creates an “uphill battle” to improve people’s health around the world. According to Doctors Without Borders some generic drugs “have reduced the organization's cost of treatment from US$10,000 per patient per year to US$140 per patient per year.” Meanwhile, in the United States, cancer treatments often cost hundreds of times what they cost elsewhere.

The pharmaceutical industry is one of the big spenders when it comes to corporate campaign contributions and lobbying in Washington. Our government’s decisions need to be made by people who take no corporate money

Read the full article on TruthOut.org: How Much of Big Pharma's Massive Profits Are Used to Influence Politicians?

Photo credit: Cross Border Action: The People's Round on the Trans Pacific Partnership by Caelie_Frampton (CC BY-NC-SA 2.0)